Lessons learnt and remaining questions after GepardNuevo results, discussed in our editorial on @Annals_Oncology Some topics 👉 are results practice changing? 👉 role of ICI after surgery? 👉 is quality of pCR different after ICI? 👉 how to deal with residual disease? @OncoAlert Tweet added by Giampaolo Bianchini @BianchiniGP

Giampaolo Bianchini

2 years

Lessons learnt and remaining questions after GepardNuevo results, discussed in our editorial on @Annals_Oncology Some topics 👉 are results practice changing? 👉 role of ICI after surgery? 👉 is quality of pCR different after ICI? 👉 how to deal with residual disease? @OncoAlert

Annals of Oncology

@Annals_Oncology

2 years

Chemo + immunotherapy has become the SoC in the neoadjuvant setting of early TNBC. In this Editorial accompanying the GeparNuevo trial results, @BianchiniGP and coll. provide presepctives on lessons learnt and remaining questions. ➡️ #bcsm